COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

Barbara Alicja Jereczek-Fossa, Matteo Pepa, Giulia Marvaso, Alessio Bruni, Michela Buglione Di Monale E Bastia, Gianpiero Catalano, Andrea Riccardo Filippi, Pierfrancesco Franco, Maria Antonietta Gambacorta, Domenico Genovesi, Giuseppe Iatì, Alessandro Magli, Luigi Marafioti, Icro Meattini, Anna Merlotti, Marcello Mignogna, Daniela Musio, Roberto Pacelli, Stefano Pergolizzi, Vincenzo TomboliniMarco Trovò, Umberto Ricardi, Stefano Maria Magrini, Renzo Corvò, Vittorio Donato

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Italy experienced one of the world's deadliest COVID-19 outbreaks and healthcare systems had to instantly reorganise activity. The Italian Radiation Oncology Departments adapted numerous solutions to minimize the disruptions. Information technologies, treatment prioritization and implementation of hypofractionation and protection procedures allowed balancing between cancer patient care and patient/healthcare workers safety.
Lingua originaleEnglish
pagine (da-a)89-93
Numero di pagine5
RivistaRadiotherapy and Oncology
Volume149
DOI
Stato di pubblicazionePubblicato - 2020

Keywords

  • AIRO (Italian Association of Radiotherapy and Clinical Oncology)
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections
  • Disease Outbreaks
  • Humans
  • Italy
  • Medical Oncology
  • Neoplasms
  • Pandemics
  • Pneumonia, Viral
  • Radiation oncology
  • SARS-CoV-2
  • Survey
  • Surveys and Questionnaires

Fingerprint

Entra nei temi di ricerca di 'COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)'. Insieme formano una fingerprint unica.

Cita questo